Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Horcajada

Showing results (111-120 of 176) with videos related to

Pageof 18
Sort By:
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coliJuan P Horcajada, María Velasco, Xavier Filella, et al.
The European Respiratory Journal|March 1, 2003
A nosocomial outbreak of influenza during a period without influenza epidemic activityJ P Horcajada, T Pumarola, J A Martínez, et al.
Plos One|April 8, 2017
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trialJudit Villar-García, Robert Güerri-Fernández, Andrés Moya, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 5, 2019
Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countriesA Marcellusi, R Viti, P Sciattella, et al.
International Journal of Antimicrobial Agents|January 28, 2017
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonateJuan P Horcajada, Luisa Sorlí, Sonia Luque, et al.
Chemical Communications (Cambridge, England)|May 28, 2015
Direct accessibility of mixed-metal (III/II) acid sites through the rational synthesis of porous metal carboxylatesS Wongsakulphasatch, F Nouar, J Rodriguez, et al.
Microbiology Spectrum|July 25, 2022
ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosaBerta Puig-Collderram, Sandra Domene-Ochoa, Maria Salvà-Comas, et al.
The Journal of Infection|January 10, 2020
Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalizationI López-Montesinos, A Domínguez-Guasch, S Gómez-Zorrilla, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 20, 2011
Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patientsMarta Crespo, Silvia Collado, Marisa Mir, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Population Pharmacokinetics of Anidulafungin in Critically Ill PatientsS Luque, W Hope, N Campillo, et al.
Pageof 18

Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coliJuan P Horcajada, María Velasco, Xavier Filella, et al.
The European Respiratory Journal|March 1, 2003
A nosocomial outbreak of influenza during a period without influenza epidemic activityJ P Horcajada, T Pumarola, J A Martínez, et al.
Plos One|April 8, 2017
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trialJudit Villar-García, Robert Güerri-Fernández, Andrés Moya, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 5, 2019
Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countriesA Marcellusi, R Viti, P Sciattella, et al.
International Journal of Antimicrobial Agents|January 28, 2017
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonateJuan P Horcajada, Luisa Sorlí, Sonia Luque, et al.
Chemical Communications (Cambridge, England)|May 28, 2015
Direct accessibility of mixed-metal (III/II) acid sites through the rational synthesis of porous metal carboxylatesS Wongsakulphasatch, F Nouar, J Rodriguez, et al.
Microbiology Spectrum|July 25, 2022
ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosaBerta Puig-Collderram, Sandra Domene-Ochoa, Maria Salvà-Comas, et al.
The Journal of Infection|January 10, 2020
Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalizationI López-Montesinos, A Domínguez-Guasch, S Gómez-Zorrilla, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 20, 2011
Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patientsMarta Crespo, Silvia Collado, Marisa Mir, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Population Pharmacokinetics of Anidulafungin in Critically Ill PatientsS Luque, W Hope, N Campillo, et al.
Pageof 18